Yarlagadda S. Babu, VP Drug Discovery at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 837 shares at $4.78 ($4K) on 2012-03-02, disclosed to the SEC on 2012-03-05.
Open-market sale of $4k BCRX by VP Drug Discovery. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BCRX | SELL | 2021-12-09 | $367K | — | Filing → |
| BCRX | BUY | 2019-11-18 | $36K | — | Filing → |
| BCRX | SELL | 2016-08-29 | $244K | — | Filing → |